Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related
- 1 May 2005
- journal article
- other
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 91 (1) , 81-87
- https://doi.org/10.1007/s10549-004-8235-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Do we need HER‐2/neu testing for all patients with primary breast carcinoma?Cancer, 2003
- Upregulation of HER-2/neu by Ovarian Ablation: Results of a Randomized Trial Comparing Leuprorelin to CMF as Adjuvant Therapy in Node-positive Breast Cancer PatientsBreast Cancer Research and Treatment, 2003
- Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer DatabasesJournal of Clinical Oncology, 2003
- HER-2/neu Overexpression and Response to Oophorectomy Plus Tamoxifen Adjuvant Therapy in Estrogen Receptor-Positive Premenopausal Women With Operable Breast CancerJournal of Clinical Oncology, 2003
- Quantitative Association Between HER-2/neu and Steroid Hormone Receptors in Hormone Receptor-Positive Primary Breast CancerJNCI Journal of the National Cancer Institute, 2003
- Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized TrialJournal of Clinical Oncology, 2001
- When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast CancerJournal of Clinical Oncology, 2001
- Prognostic Factors in Breast CancerArchives of Pathology & Laboratory Medicine, 2000
- Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levelsBreast Cancer Research and Treatment, 2000
- Predicting Response to Endocrine Therapy in Human Breast Cancer: A HypothesisScience, 1975